1. Polonsky KS, O'Meara NM. Secretion and metabolism of insulin, proinsulin and C-peptide. In: DeGroot LJ, ed. Endocrinology. Philadelphia: WB Saunders Company; 1995:1354-1372.
2.
2. Amico JA, Klein I. Diabetic management in patients with renal failure. Diabetes Care. 1981;4:430-434.
3.
3. Arem R. Hypoglycemia associated with renal failure. Endocrinol Metab Clin North Am. 1989;18:103-121.
4.
4. Scaramuzza A, Castellani G, Lorini R. Insulin abuse in an adolescent with insulin-dependent diabetes mellitus [letter]. Eur J Pediatr. 1996;155:526-526.
5.
5. Sjobom NC, Adamson U, Lin PE. The prevalence of impaired glucose counterregulation during an insulin-infusion test in insulin-treated diabetic patients prone to severe hypoglycaemia. Diabetologia. 1989;32:818-825.
6.
6. Felig P, Brown WV, Levine RA, et al. Glucose homeostasis in viral hepatitis. NEnglJMed. 1970;283:1436-1440.
7.
7. Record CO, Alberti KG, Williamson DH, et al. Glucose tolerance and metabolic changes in human viral hepatitis. Clin Sci Mol Med. 1973;45:677-690.
8.
8. Petrides AS, Stanley T, Matthews DE, et al. Insulin resistance in cirrhosis: prolonged reduction of hyperinsulinemia normalizes insulin sensitivity. Hepatology. 1998;28:141-149.
9.
9. Service FJ. Hypoglycemia, including hypoglycemia in neonates and children. In: DeGroot LJ, ed. Endocrinology. Philadelphia: WB Saunders Company; 1995:1605-1623.
10.
10. Leschke M, Rumpf KW, Eisenhauer T, et al. Quantitative assessment of carnitine loss during hemodialysis and hemofiltration. Kidney Int Suppl. 1983; 16:S143-S146.
